<DOC>
	<DOC>NCT01337206</DOC>
	<brief_summary>The SX-ELLA Stent Esophageal Degradable BD (BD Stent) is designed for dilation of benign esophageal lesions, namely: (1) stenosis (peptic, anastomotic or caustic) refractory to standard therapy, (2) achalasia refractory to standard therapy.</brief_summary>
	<brief_title>SX ELLA Esophageal Degradable BD Stent System</brief_title>
	<detailed_description />
	<criteria>A recurrent benign esophageal stricture due to all causes (surgery, radiation therapy, corrosive ingestion, peptic injury, PDT, or other ablative therapy) Patient &lt; 18 years old Patient is unwilling or unable to sign and date the informed consent Patient is unwilling or unable to comply with the followup schedule Patient is pregnant, breastfeeding, or planning to become pregnant in the next 12 months Patient is simultaneously participating in another drug or device study or the patient has completed the followup phase for the primary objective of any previous study less than 30 days prior to enrollment in this study Patient with a life expectancy &lt; 12 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Esophageal Stenosis</keyword>
	<keyword>Esopageal Strictures</keyword>
	<keyword>Esophageal Dysphagia</keyword>
</DOC>